GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (HAM:LL3) » Definitions » Interest Expense

PanGenomic Health (HAM:LL3) Interest Expense : €-0.04 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is PanGenomic Health Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. PanGenomic Health's interest expense for the three months ended in Sep. 2024 was € 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.04 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. PanGenomic Health's Operating Income for the three months ended in Sep. 2024 was € -0.13 Mil. PanGenomic Health's Interest Expense for the three months ended in Sep. 2024 was € 0.00 Mil. PanGenomic Health has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.


PanGenomic Health Interest Expense Historical Data

The historical data trend for PanGenomic Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PanGenomic Health Interest Expense Chart

PanGenomic Health Annual Data
Trend Dec21 Dec22 Dec23
Interest Expense
- - -0.03

PanGenomic Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.01 -

PanGenomic Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PanGenomic Health  (HAM:LL3) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PanGenomic Health's Interest Expense for the three months ended in Sep. 2024 was €0.00 Mil. Its Operating Income for the three months ended in Sep. 2024 was €-0.13 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was €0.00 Mil.

PanGenomic Health's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

PanGenomic Health had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


PanGenomic Health Business Description

Comparable Companies
Traded in Other Exchanges
Address
3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9
PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

PanGenomic Health Headlines

No Headlines